← Leaderboards
Ann J Melvin
University Of Washington
$12,425
Attributed
$12,425
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.2K · FY2006–07$10K$7.5K$5K$2.5K$0
'06
'07
Funding mix
By agency
NIH$12,425 · 4
By mechanism
M01$12,425 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Jashvant D Unadkat$14,909,800
- Laura A Koutsky$14,115,377
- Allan Edward Rettie$24,434,501
- Nancy B. Kiviat$21,349,193
- Anna Wald$34,443,936
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyChildUnited States National Institutes Of HealthFundingResourcesSourceGrantResearch PersonnelInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseAnti-Retroviral AgentsAdultDrug KineticsSiteDoseProtocols, TreatmentLicensingPharmaceutical PreparationsProtease InhibitorComb Animal StructureCholesterolChildhoodAids Clinical Trial GroupDrug Combinations
Grant awards (4)
PHARMACOKINETIC & SAFETY STUDY OF PROTEASE INHIBITOR IN COMB IN HIV INFECTED$1,963
M01 · FY2007 · RR · contact PI
PACTG 1047: STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS VIRUS LIKE VACCINE IN HIV$736
M01 · FY2007 · RR · contact PI
PACTG(PEDIATRIC AIDS CLINICAL TRIAL GROUP) 1058 : PHARMACOKINETIC STUDIES$491
M01 · FY2007 · RR · contact PI
PHARMACOKINETIC AMP; SAFETY STUDY OF PROTEASE INHIBITOR IN COMB IN HIV INFECTED$9,235
M01 · FY2006 · RR · contact PI